Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring

BACKGROUND: Direct-acting antiviral agents (DAAs) cure patients with hepatitis C virus (HCV) infection. Concerns have arisen the occurrence of significant bradyarrhythmias during treatment with DAAs. The aim of this study was to assess the impact of a DAA combination for the treatment of HCV infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: El Missiri, Ahmed Mohamed, Rayan, Mona Mostafa, Awad, Mohamed Medhat, El Desoky, Ahmed Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329943/
https://www.ncbi.nlm.nih.gov/pubmed/32613565
http://dx.doi.org/10.1186/s43044-020-00070-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329943/
https://www.ncbi.nlm.nih.gov/pubmed/32613565
http://dx.doi.org/10.1186/s43044-020-00070-4

Ejemplares similares